Nath Bio-Genes (India) Limited
Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; fruit seeds; and seeds for vegetables comprisi… Read more
Market Cap & Net Worth: Nath Bio-Genes (India) Limited (NATHBIOGEN)
Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) has a market capitalization of $30.81 Million (₹2.67 Billion) as of March 18, 2026. Listed on the NSE stock exchange, this India-based company holds position #28568 globally and #1540 in its home market, demonstrating a -1.98% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nath Bio-Genes (India) Limited's stock price ₹140.41 by its total outstanding shares 19004000 (19.00 Million).
Nath Bio-Genes (India) Limited Market Cap History: 2015 to 2026
Nath Bio-Genes (India) Limited's market capitalization history from 2015 to 2026. Data shows growth from $16.30 Million to $30.81 Million (4.01% CAGR).
Nath Bio-Genes (India) Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nath Bio-Genes (India) Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
Nath Bio-Genes (India) Limited's market cap is 0.01 times its annual revenue
0.23x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.09x
Nath Bio-Genes (India) Limited's market cap is 0.09 times its annual earnings
5.23x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $31.03 Million | $1.62 Billion | $141.67 Million | 0.02x | 0.22x |
| 2017 | $97.02 Million | $1.70 Billion | $162.82 Million | 0.06x | 0.60x |
| 2018 | $87.55 Million | $1.92 Billion | $294.19 Million | 0.05x | 0.30x |
| 2019 | $72.22 Million | $2.31 Billion | $384.33 Million | 0.03x | 0.19x |
| 2020 | $57.25 Million | $2.80 Billion | $504.84 Million | 0.02x | 0.11x |
| 2021 | $55.58 Million | $3.07 Billion | $556.62 Million | 0.02x | 0.10x |
| 2022 | $34.39 Million | $2.78 Billion | -$673.38 Million | 0.01x | N/A |
| 2023 | $45.11 Million | $3.01 Billion | $350.11 Million | 0.01x | 0.13x |
| 2024 | $40.94 Million | $2.48 Billion | $396.19 Million | 0.02x | 0.10x |
| 2025 | $34.12 Million | $3.65 Billion | $386.00 Million | 0.01x | 0.09x |
Competitor Companies of NATHBIOGEN by Market Capitalization
Companies near Nath Bio-Genes (India) Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Nath Bio-Genes (India) Limited by market ranking:
- Corteva Inc (NYSE:CTVA): Ranked #406 globally with a market cap of $53.70 Billion USD.
- Nutrien Ltd (NYSE:NTR): Ranked #615 globally with a market cap of $34.02 Billion USD.
- Qinghai Salt Lake Industry Co.Ltd (SHE:000792): Ranked #1164 globally with a market cap of $16.27 Billion USD ( CN¥119.40 Billion CNY).
- CF Industries Holdings Inc (NYSE:CF): Ranked #1215 globally with a market cap of $15.33 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #406 | Corteva Inc | NYSE:CTVA | $53.70 Billion | $80.05 |
| #615 | Nutrien Ltd | NYSE:NTR | $34.02 Billion | $79.55 |
| #1164 | Qinghai Salt Lake Industry Co.Ltd | SHE:000792 | $16.27 Billion | CN¥36.15 |
| #1215 | CF Industries Holdings Inc | NYSE:CF | $15.33 Billion | $123.29 |
Nath Bio-Genes (India) Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Nath Bio-Genes (India) Limited's market cap moved from $16.30 Million to $ 30.81 Million, with a yearly change of 4.01%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹30.81 Million | -9.70% |
| 2025 | ₹34.12 Million | -16.65% |
| 2024 | ₹40.94 Million | -9.25% |
| 2023 | ₹45.11 Million | +31.16% |
| 2022 | ₹34.39 Million | -38.12% |
| 2021 | ₹55.58 Million | -2.93% |
| 2020 | ₹57.25 Million | -20.72% |
| 2019 | ₹72.22 Million | -17.52% |
| 2018 | ₹87.55 Million | -9.76% |
| 2017 | ₹97.02 Million | +212.63% |
| 2016 | ₹31.03 Million | +90.38% |
| 2015 | ₹16.30 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Nath Bio-Genes (India) Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $30.81 Million USD |
| MoneyControl | $30.81 Million USD |
| MarketWatch | $30.81 Million USD |
| marketcap.company | $30.81 Million USD |
| Reuters | $30.81 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.